Investor Communications
NorthStar Healthcare Conference Call - Q3 2021 Results and Updated Net Asset Value
Monday, November 22, 2021
Replay
Supplemental Financial Reports
Third Quarter 2021 Financial Supplement – 11.12.21
Second Quarter 2021 Financial Supplement – 8.13.21
First Quarter 2021 Financial Supplement - 5.14.21
Year Ended 2020 Financial Supplement - 3.23.21
Financial Supplemental Update - 1.27.21
Third Quarter 2020 Financial Supplement - 9.30.20
Second Quarter 2020 Financial Supplement - 8.13.20
COVID-19 Update Supplement – 5.27.2020
First Quarter 2020 Financial Supplement – 5.08.2020
Year Ended 2019 Financial Supplement - 3.23.20
Third Quarter 2019 Financial Supplement - 11.14.19
Second Quarter 2019 Financial Supplement - 8.19.19
First Quarter 2019 Financial Supplement - 6.14.19
Shareholder Letters
Response to Comrit Tender Offer - 4.27.2021
June 30, 2020 Estimated Per Share Value - 12.21.2020
Response to Comrit Tender Offer - 12.4.2020
Share Repurchase Program Suspension - 4.14.2020
June 30, 2019 Estimated Per Share Value - 12.11.2019
Response to Comrit Tender Offer - 12.11.2019
Monthly Distribution Suspension - 2.7.2019
Amended Share Repurchase Program - 10.15.2018
Response to MacKenzie Tender Offer - 8.13.2018
Frequently Asked Questions
On February 7, 2019, NorthStar Healthcare Income, Inc. (the Company) filed a Form 8-K with the Securities and Exchange Commission (SEC) in which the Company announced the suspension of its monthly distribution payments to stockholders. Set forth below are the Company's responses to certain of the more frequently asked questions. For additional information regarding the Company please see the Company’s filings with the SEC.
Download the Frequently Asked Questions PDF